Kevin Garey
University of Houston
H-index: 58
North America-United States
Top articles of Kevin Garey
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
A Randomized, Double-Blind, Phase 3 Safety and Efficacy Study of Ridinilazole Versus Vancomycin for Treatment of Clostridioides difficile Infection: Clinical … | Clinical Infectious Diseases | Pablo C Okhuysen Mayur S Ramesh Thomas Louie Nino Kiknadze Julian Torre-Cisneros | 2024/2/2 |
Increased Prevalence of Clostridioides difficile Infection Among Pediatric Oncology Patients: Risk Factors for Infection and Complications | The Pediatric Infectious Disease Journal | Brianna R Murphy Natalie J Dailey Garnes Hyunsoo Hwang Christine B Peterson Kevin W Garey | 2024/2/1 |
Development and validation of LC-MS/MS for quantifying omadacycline from stool for gut microbiome studies | Journal of Chromatography B | Chenlin Hu Weiqun Wang Jinhee Jo Kevin W Garey | 2024/2/28 |
Fecal Pharmacokinetics and Gut Microbiome Effects of Oral Omadacycline Versus Vancomycin in Healthy Volunteers | The Journal of Infectious Diseases | Jinhee Jo Chenlin Hu Khurshida Begum Weiqun Wang Thanh M Le | 2024/1/15 |
Reduced Vancomycin Susceptibility in Clostridioides difficile is Associated with Lower Rates of Initial Cure and Sustained Clinical Response | Clinical Infectious Diseases | Taryn A Eubank Chetna Dureja Kevin W Garey Julian G Hurdle Anne J Gonzales-Luna | 2024/2/21 |
Efficacy and Health-Related Quality of Life Impact of Fecal Microbiota, Live-jslm: A Post Hoc Analysis of PUNCH CD3 Patients at First Recurrence of Clostridioides difficile … | Infectious Diseases and Therapy | Paul Feuerstadt Jessica R Allegretti Erik R Dubberke Amy Guo Adam Harvey | 2024/1 |
Antibacterial activity of ibezapolstat against antimicrobial-resistant clinical strains of Clostridioides difficile | Antimicrobial Agents and Chemotherapy | Eugénie Bassères Taryn A Eubank Khurshida Begum M Jahangir Alam Jinhee Jo | 2024/2/16 |
Healthcare Resource Utilization and Discharge Readiness in Adult Hospitalized Patients With Candidemia or Invasive Candidiasis Who Received an Echinocandin: An Analysis of … | Open Forum Infectious Diseases | Thomas P Lodise Kevin W Garey Jalal A Aram Brian H Nathanson | 2024/1 |
Microscopy methods for Clostridioides difficile | Chenlin Hu Kevin W Garey | 2024/2/8 | |
Comparison of Risk Stratification Approaches to Identify Patients with Clostridioides difficile Infection at Risk for Multidrug-Resistant Organism Gut Microbiota … | Infectious Diseases and Therapy | Evan J Zasowski Maryam Ali Ada Anugo Nayle Ibragimova Kierra M Dotson | 2023/8 |
S1083 Association of Microbiome Composition and Health-Related Quality of Life in Patients With Recurrent Clostridioides difficile Infection: Results From the PUNCH CD3 Phase 3 … | Official journal of the American College of Gastroenterology| ACG | Paul Feuerstadt Ken Blount Amy Guo Min Yang Viviana García-Horton | 2023/10 |
Omadacycline and Clostridioides difficile: A Systematic Review of Preclinical and Clinical Evidence | Kevin W Garey Warren Rose Kyle Gunter Alisa W Serio Mark H Wilcox | 2023/2 | |
Validation of a Health-Related Quality of Life Questionnaire in Patients With Recurrent Clostridioides difficile Infection in ECOSPOR III, a Phase 3 Randomized Trial | Clinical Infectious Diseases | Brittany Lapin Kevin W Garey Henry Wu Sissi V Pham Shirley P Huang | 2023/2/1 |
277. A Functional OMICs Evaluation of Omadacycline to Understand Anti-Clostridioides difficile Protective Effects | Open Forum Infectious Diseases | Jinhee Jo Samantha Agyapong Chenlin Hu Weiqun Wang Anne J Gonzales-Luna | 2023/12 |
The Novel DNA Binding Mechanism of Ridinilazole, a Precision Clostridiodes difficile Antibiotic | Antimicrobial Agents and Chemotherapy | Clive S Mason Tim Avis Chenlin Hu Nabeetha Nagalingam Manikhandan Mudaliar | 2023/5/17 |
Gut microbiota changes associated with Clostridioides difficile infection and its various treatment strategies | Anne J Gonzales-Luna Travis J Carlson Kevin W Garey | 2023/12/31 | |
Detectable Vancomycin Stool Concentrations in Hospitalized Patients with Diarrhea Given Intravenous Vancomycin | Pharmacoepidemiology | Taryn A Eubank Chenlin Hu Anne J Gonzales-Luna Kevin W Garey | 2023/9/28 |
Decoding a cryptic mechanism of metronidazole resistance among globally disseminated fluoroquinolone-resistant Clostridioides difficile | Nature Communications | Abiola O Olaitan Chetna Dureja Madison A Youngblom Madeline A Topf Wan-Jou Shen | 2023/7/12 |
Emerging Options for the Prevention and Management of Clostridioides difficile Infection | Anne J Gonzales-Luna Travis J Carlson Kevin W Garey | 2023/2 | |
366. Association Between Gut Microbiota and Health-Related Quality of Life in Patients with Recurrent Clostridioides difficile Infection: Results from the PUNCH … | Open Forum Infectious Diseases | Paul Feuerstadt Ken Blount Amy Guo Min Yang Viviana García-Horton | 2023/12 |
Co-Authors
